Discover
INDV
Indivior Pharmaceuticals, Inc.
40.25
2 x 29.24
2 x 51.69
bid
ask
-
0.78
1.90%
2 @ 04:00 PM
40.00 -0.25 (0.62%)
| Ytd | 12.18% | |
| 1y | 174.56% |
39.92
day range
41.88
14.55
52 week range
42.81
| Open | 41.27 | Prev Close | 41.03 | Low | 39.92 | High | 41.88 | Mkt Cap | 4.76B |
| Vol | 1.45M | Avg Vol | 1.98M | EPS | 1.95 | P/E | 20.64 | Forward P/E | 9.72 |
| Beta | 1.17 | Short Ratio | 7.05 | Inst. Own | 107.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 06-16 | Earning | 04-30 | 50-d Avg | 37.58 | 200-d Avg | 32.68 | 1yr Est | 50.83 |
| Income Statement | |||
| Total Revenue | 317.00M | ||
| Revenues (USD) | 317.00M | ||
| Cost of Revenue | 40.00M | ||
| Gross Profit | 277.00M | ||
| Operating Expenses | 140.00M | ||
| Research and Development Expense | 16.00M | ||
| Selling, General and Administrative Expense | 124.00M | ||
| Operating Income | 137.00M | ||
| Interest Expense | 7.00M | ||
| Income Tax Expense | 26.00M | ||
| Net Income | 89.00M | ||
| Net Income Common Stock | 89.00M | ||
| Net Income Common Stock (USD) | 89.00M | ||
| Consolidated Income | 89.00M | ||
| Earnings per Basic Share | 0.71 | ||
| Earnings per Basic Share (USD) | 0.71 | ||
| Earnings per Diluted Share | 0.69 | ||
| Earning Before Interest & Taxes (EBIT) | 122.00M | ||
| Earning Before Interest & Taxes (USD) | 122.00M | ||
| Weighted Average Shares | 124.00M | ||
| Weighted Average Shares Diluted | 129.00M | ||
| Balance Sheet | |||
| Cash and Equivalents | 175.00M | ||
| Cash and Equivalents (USD) | 175.00M | ||
| Investments | 27.00M | ||
| Investments Non-Current | 27.00M | ||
| Trade and Non-Trade Receivables | 273.00M | ||
| Current Assets | 667.00M | ||
| Property, Plant & Equipment Net | 179.00M | ||
| Total Assets | 1.20B | ||
| Debt Current | 9.00M | ||
| Total Debt | 509.00M | ||
| Current Liabilities | 779.00M | ||
| Debt Non-Current | 500.00M | ||
| Total Liabilities | 1.34B | ||
| Accumulated Retained Earnings (Deficit) | -280.00M | ||
| Accumulated Other Comprehensive Income | -29.00M | ||
| Shareholders Equity | -144.00M | ||
| Shareholders Equity (USD) | -144.00M | ||
| Assets Non-Current | 530.00M | ||
| Total Debt (USD) | 509.00M | ||
| Goodwill and Intangible Assets | 2.00M | ||
| Inventory | 152.00M | ||
| Liabilities Non-Current | 562.00M | ||
| Trade and Non-Trade Payables | 178.00M | ||
| Tax Assets | 308.00M | ||
| Tax Liabilities | 26.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.00M | ||
| Net Cash Flow from Financing | 7.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -20.00M | ||
| Capital Expenditure | -20.00M | ||
| Issuance (Purchase) of Equity Shares | -147.00M | ||
| Issuance (Repayment) of Debt Securities | 151.00M | ||
| Net Cash Flow from Investing | -19.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 1000.00K | ||
| Net Cash Flow from Operations | -9.00M | ||
| Share Based Compensation | 9.00M | ||